Clarissa E. Johnson
Duke University
8 Papers
56 Citations
Clarissa E. Johnson is an academic researcher from Duke University. The author has contributed to research in topics: Congenital dyserythropoietic anemia & Congenital dyserythropoietic anemia type I. The author has an hindex of 2, co-authored 6 publications.
Chat about Author
Papers
Adhesion molecules and hydroxyurea in the pathophysiology of sickle cell disease
TL;DR: Hydroxyurea treatment has proven clinical benefit in sickle cell disease, and Drs.
54
Adhesion molecules and hydroxyurea in the pathophysiology of sickle cell disease
TL;DR: Hydroxyurea treatment has proven clinical benefit in sickle cell disease, and Drs.
26
Real World Evidence of Prescription Patterns and Effect of Oxbryta (voxelotor) for Patients with Sickle Cell Disease
Nirmish Shah,Ahmar U. Zaidi,Michael U. Callaghan,Darla K. Liles,Clarissa E. Johnson,Laura M. De Castro +5 more
TL;DR: Real world evidence of prescribing patterns and initial outcomes from the use of newly approved voxelotor is presented and several patients reported 'more energy' and improvement in 'morning achiness' and 'quality of life', while a few patients noted no change in stamina or well-being.
3
The First Registry for Patients with Congenital Dyserythropoietic Anemia in North America: Design and Preliminary Results
Omar Niss,Robert B. Lorsbach,Georgios E Christakopoulos,Lisa Trump,Megan Reynolds,Katie M. Giger,Clarissa E. Johnson,Ammar Husami,David Buchbinder,Jennifer A. Rothman,Gavin D. Roach,Adrienne Lee,Vinod Gidvani-Diaz,Morgan L. McLemore,Satheesh Chonat,Adam S. Nelson,James B. Ball,Bruce J. Aronow,Carolyn Lutzko,Kejian Zhang,Theodosia A. Kalfa +20 more
TL;DR: CDAR will provide a longitudinal database and a biorepository to facilitate natural history studies and molecular pathways research in Congenital Dyserythropoietic Anemias and be a collaborative resource for patients, treating physicians, and investigators.
2
VPS4A : A Novel Candidate Gene for Congenital Dyserythropoietic Anemia
Katie M. Giger,Georgios E Christakopoulos,Lisa Trump,Clarissa E. Johnson,Haripriya Sakthivel,Mary Risinger,Omar Niss,Kejian Zhang,Lionel Blanc,Robert B. Lorsbach,Paritha Arumugam,Carolyn Lutzko,Carolyn Lutzko,Theodosia A. Kalfa +13 more
TL;DR: In this paper, a 2 y.o. female patient with transfusion dependent anemia, pathologic diagnosis of Congenital Dyserythropoietic Anemia type I (CDA-I), and neurodevelopmental delay was enrolled in CDAR.
2